You are here

Vishuo databases aim at targeted medical treatments

Singapore-based health-care tech firm to take its product beyond hospitals in China, Australia and the US, and finds itself up against bigger players such as Thomson Reuters

Vishuo's managing director Guo Dongliang said: "We help build a database to construct data between genes, drugs and diseases." Vishuo's database will eventually incorporate other analysis parameters such as patients' lifestyles, work environment and family history.


WHEN conventional treatments such as surgery and chemotherapy failed to work for a lung-cancer patient after three years, he turned to Vishuo Biomedical for a course of treatment targeted at his particular gene profile.

The Singapore-based health-care technology company